Description

Racotumomab is a therapeutic monoclonal antibody designed for active immunotherapy. This innovative compound is significant for its targeted approach in specific therapeutic areas, representing a sophisticated tool in advanced biomedical research and development. It is primarily utilized by pharmaceutical R&D teams, biotechnology companies, and clinical research organizations focused on developing novel immunotherapies and targeted treatments.

Application

• Immunotherapy Research: A key investigational agent in the development of active specific immunotherapies for targeted clinical applications.
• Biopharmaceutical Development: Serves as a critical reference standard and active pharmaceutical ingredient (API) in the formulation and stability testing of novel biologic drugs.
• Preclinical & Clinical Studies: Used in animal models and human clinical trials to evaluate efficacy, pharmacokinetics, and safety profiles.
• Mechanism of Action Studies: Employed in biochemical and cellular assays to study immune system modulation and specific antigen targeting.
• Diagnostic Reagent Development: Can be utilized in the development of companion diagnostic tests to identify patient populations likely to respond to therapy.

Basic Information

Product Name	Racotumomab
CAS No.	946832-34-4
Molecular Formula	Contact for details
Molecular Weight	Contact for details
Synonyms	Racotumomab; Anti-NeuGcGM3 Monoclonal Antibody; Vaxira; 1E10 Anti-Idiotype Mab; 1E10; Anti-Idiotypic Mab 1E10; Racotumomab (USAN); UNII-6V7V385A0D; 6V7V385A0D
EINECS	Contact for details

Quality Control

Our Racotumomab is produced and controlled under a strict quality management system. Each batch undergoes comprehensive analytical testing, including purity assessment by HPLC, identity confirmation, and biological activity assays, to ensure it meets the stringent requirements for research and development use. Certificates of Analysis (COA) with detailed specifications are provided for every shipment.

Storage

Preserve in a tightly closed container, protected from light. For long-term stability, store lyophilized material at -20°C or below. Reconstituted solutions should be aliquoted and stored at recommended temperatures to avoid repeated freeze-thaw cycles. Store in a dry, well-ventilated area.

Specification

Item	Specification
Appearance	White to off-white lyophilized powder
Identification (HPLC)	Conforms to reference standard
Purity (SDS-PAGE)	≥ 95%
Protein Content	≥ 90%
Endotoxin	< 1.0 EU/mg
Sterility (Membrane Filtration)	Sterile
Biological Activity (ELISA/Binding)	Conforms to reference
Moisture Content (Karl Fischer)	< 3.0%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.